Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
Abstract INTRODUCTION Minimal clinically important differences (MCIDs) for Alzheimer's disease (AD) have previously been estimated using clinician‐based anchors. However, MCIDs have been criticized for not reflecting the preferences of people living with AD (PLWAD). Furthermore, interpretations...
Saved in:
| Main Authors: | Krista Lanctot, Linus Jönsson, Alireza Atri, Russ Paulsen, Soeren Mattke, Julie Hviid Hahn‐Pedersen, Pepa Polavieja, Thomas Maltesen, Teresa León, Anders Gustavsson, Alzheimer's Disease Neuroimaging Initiative |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.70081 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
by: Takuya Yagi, et al.
Published: (2019-01-01) -
Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
by: Laurie Eliason, et al.
Published: (2024-12-01) -
Therapeutic time window of disease‐modifying therapy for early Alzheimer's disease
by: Saki Nakashima, et al.
Published: (2025-04-01) -
Assessing clinical meaningfulness in clinical trials for Alzheimer's disease: A U.S. regulatory perspective
by: Teresa Buracchio, et al.
Published: (2025-04-01) -
How do we put meaning into meaningful benefit? Perspectives from the lived experience
by: Russ Paulsen, et al.
Published: (2025-04-01)